Company Filing History:
Years Active: 1995-2013
Title: **Michel M. Chartrain: Innovator in Plasmid DNA Production**
Introduction
Michel M. Chartrain, based in Westfield, NJ, is a notable inventor recognized for his contributions to the field of biotechnology. With a total of 19 patents, Chartrain has made significant strides in the methods of plasmid DNA production, a vital aspect of modern biomedical research and applications.
Latest Patents
Among Chartrain's most recent patents, one invention focuses on a method for increasing the yield of plasmid DNA production. This innovative process involves selecting a highly productive clonal subtype of a strain, notably the DH5 strain, which carries a DNA plasmid. By cultivating this clonal subtype through fed-batch fermentation in a chemically-defined medium, record quantities of plasmid DNA can be generated on an industrial scale. This method has potential applications in producing pharmaceutical-grade DNA for use in polynucleotide vaccinations and gene therapy treatments.
Career Highlights
Chartrain has held prominent positions in renowned companies such as Merck & Company and Merck Sharp & Dohme Corporation. his work at these organizations further emphasizes his expertise and commitment to advancing biotechnological solutions.
Collaborations
Throughout his career, Michel M. Chartrain has collaborated with accomplished professionals like Christopher Roberge and Brian Heimbuch. These partnerships reflect the collaborative nature of innovation in the biotech industry, where teamwork often leads to groundbreaking advancements.
Conclusion
Michel M. Chartrain stands as a key figure in the realm of plasmid DNA production, exemplifying the spirit of innovation in biotechnology. His patents not only highlight his inventiveness but also promise significant benefits for the future of medicine, especially in developing therapies and vaccinations. As he continues his work, the impact of his contributions is sure to resonate within the scientific community.